Psychedelic treatments have been considered in the treatment of mental health since the 1950s, following Albert Hofmann’s development of lysergic acid diethylamide (LSD-25) in 1938. Government intervention and regulation throughout the 1970s slowed potential medical development, but recent success in clinical trials has suggested that mind-altering substances could present an opportunity, particularly within the treatment of mental health conditions including depression, anxiety, post-traumatic stress disorder (PTSD), eating disorders and substance abuse disorders.
Read the full article: Psychedelic Treatments for Mental Health: Is There Substance behind the Hype? //
Source: https://www.clinicaltrialsarena.com/analysis/psychedelic-treatments-for-mental-health-is-there-substance-behind-the-hype